Hacker News new | ask | show | jobs
by jryio 87 days ago
We finally found the first morbidity signal of GLP-1s (or lack thereof).

These are life changing drugs, but like plastic we'll see their effects in force within this generation:

> The longer time spent off GLP-1s, the greater the risk of major cardiovascular events—up to 22 percent for those who abstained for two years.

3 comments

Doesn't it make sense that, if you were taking a drug that reduces morbidity, you'll get increased morbidity if you stop it?
Not if having a heart attack within 1 year at a higher rate is an co-morbidity factor when the primary treatment was for obesity or diabetes (not stating that obesity and heart disease are not positively correlated).

To use a dense analogy: if I stopped brushing my teeth I would not expect to die of gum disease.

I don't think you read the study. The people returned to their pre treatment risk profile after ceasing treatment
You are misunderstanding the study (largely because the article heavily misrepresents it, would be my guess)

They do not see an increase against their pre-GLP1 baseline risk - they see a reversal of the cardioprotective benefits the drug provided while they were on it.

You failed to understand the results of the study and quoted a passage that does not in any way support your assertion.